// App-Quantinova.ai

1320 : Local and sustained delivery of tamoxifen for the prevention of ER+ breast cancer using a nanochannel delivery platform

Researchers

Presenter

  • Carly S. Filgueira

Principal Investigators

  • Eugenia Nicolov

  • Andrea Ballerini

  • R. Lyle Hood

  • Priya Jain

  • Giacomo Bruno

  • Alessandro Grattoni

Medical Centers

  • Houston Methodist Research Institute, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Endometrial Cancer

  • Breast cancer

  • Cataract

  • Solid malignancies

  • Stroke

Biomarkers

  • Neuromedin-U

Drug/Treatment

  • Raloxifene

  • Tamoxifen

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A